Filing Details

Accession Number:
0001209191-22-024534
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-04-15 18:24:23
Reporting Period:
2022-04-13
Accepted Time:
2022-04-15 18:24:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1527753 Personalis Inc. PSNL Services-Medical Laboratories (8071) 275411038
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1779811 Stephen John West C/O Personalis, Inc.
1330 O'Brien Drive
Menlo Park CA 94025
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-04-13 64,430 $1.84 404,221 No 4 M Direct
Common Stock Disposition 2022-04-13 64,430 $0.00 339,791 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-04-13 64,430 $0.00 64,430 $1.84
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-12-11 No 4 D Direct
Footnotes
  1. The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. This reflects a reduction of 13 shares due to a scrivener's error on the reporting person's prior filings and does not indicate a purchase and/or sale of such shares.
  3. The weighted average sale price for the transaction reported was $7.40, and the range of prices were between $7.31 and $7.57. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
  4. The shares subject to the option are fully vested and exercisable.